Evidence Level
Palmitoylethanolamide (PEA), identified in the 1950s, has been extensively studied for its analgesic properties. A comprehensive meta-analysis by Paladini et al. (2016) involving 12 randomized controlled trials (RCTs) with 603 participants demonstrated that PEA significantly reduces chronic pain intensity by 1.04 points every two weeks compared to control. This finding was supported by Schweiger et al. (2024), who conducted a systematic review and meta-analysis of nine studies (742 patients) and found that extended treatment with micron-size PEA for 60 days significantly reduced chronic pain compared to 30 days of treatment (1.36 points, p < 0.01).
PEA's mechanisms include activation of peroxisome proliferator-activated receptor alpha (PPAR-alpha), which reduces inflammation by inhibiting NF-kB signaling, and stabilization of mast cells via the ALIA mechanism. Unlike cannabinoids, PEA does not bind to CB1 or CB2 receptors, avoiding psychoactive effects. It also enhances anandamide signaling indirectly by inhibiting fatty acid amide hydrolase (FAAH).
Micronized forms of PEA improve bioavailability and efficacy. A systematic review by Bortoletto et al. (2025) of 47 RCTs involving 48 studies highlighted that PEA supplementation improves pain management and general well-being with good tolerability in patient populations.
Recent studies further validate PEA's safety and efficacy. Rao et al. (2025) conducted a randomized, double-blind, placebo-controlled crossover trial (n=18) and found that 300 mg of PEA significantly reduced acute menstrual pain scores compared to placebo at multiple time points. Additionally, Cornali et al. (2025) reported in a pilot study (n=19) that a food supplement containing co-micronized PEA-rutin and hydroxytyrosol significantly reduced body weight, BMI, fat mass, and inflammation biomarkers in metabolic syndrome patients compared to placebo.
Overall, PEA's remarkable safety profile—characterized by its lack of psychoactive effects and good tolerability—makes it a promising option for pain management and other health applications.